Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

NCT02823951 · clinicaltrials.gov ↗

COMPLETED

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing-remitting Multiple Sclerosis

Interventions

DRUG: Rebif
DRUG: Tecfidera

Sponsor

IMS HEALTH GmbH & Co. OHG

Collaborators

[object Object]